Your browser doesn't support javascript.
loading
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Pérez-Alea, M; McGrail, K; Sánchez-Redondo, S; Ferrer, B; Fournet, G; Cortés, J; Muñoz, E; Hernandez-Losa, J; Tenbaum, S; Martin, G; Costello, R; Ceylan, I; Garcia-Patos, V; Recio, J A.
Affiliation
  • Pérez-Alea M; Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • McGrail K; Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • Sánchez-Redondo S; Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • Ferrer B; Biomedical Research in Melanoma-Animal Models and Cancer Laboratory-Oncology Program, Vall d'Hebron Research institute VHIR-Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • Fournet G; Anatomy Pathology Department, Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • Cortés J; Institut de Chimie et Biochimie Moléculaire et Supramoléculaire, UMR-CNRS 5246, Université de Lyon, Université Claude Bernard-Lyon1, Villeurbanne, France.
  • Muñoz E; Ramon y Cajal University Hospital, Madrid, Spain.
  • Hernandez-Losa J; Clinical Oncology Program, Vall d'Hebron Institute of Oncology-VHIO, Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • Tenbaum S; Clinical Oncology Program, Vall d'Hebron Institute of Oncology-VHIO, Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • Martin G; Anatomy Pathology Department, Vall d'Hebron Hospital, Barcelona-UAB, Spain.
  • Costello R; Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Ceylan I; Advanced BioDesign, Parc Technologique de Lyon, Woodstock - Bâtiment Cèdre 1, Saint Priest, France.
  • Garcia-Patos V; Service d'Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire La Conception, Marseille, France.
  • Recio JA; Advanced BioDesign, Parc Technologique de Lyon, Woodstock - Bâtiment Cèdre 1, Saint Priest, France.
Oncogene ; 36(41): 5695-5708, 2017 10 12.
Article in En | MEDLINE | ID: mdl-28581514
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfhydryl Compounds / Aldehyde Oxidoreductases / Alkynes / Melanocytes / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfhydryl Compounds / Aldehyde Oxidoreductases / Alkynes / Melanocytes / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: España